Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Receivables: 2010-2025

Historic Change in Receivables for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $16.3 million.

  • Prestige Consumer Healthcare's Change in Receivables rose 439.15% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 865.56%. This contributed to the annual value of $16.3 million for FY2025, which is 158.26% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Change in Receivables of $16.3 million as of FY2025, which was up 158.26% from $6.3 million recorded in FY2024.
  • Prestige Consumer Healthcare's Change in Receivables' 5-year high stood at $24.9 million during FY2023, with a 5-year trough of -$36.9 million in FY2021.
  • Over the past 3 years, Prestige Consumer Healthcare's median Change in Receivables value was $16.3 million (recorded in 2025), while the average stood at $15.9 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 1,394.21% in 2021, then spiked by 166.86% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Change in Receivables (Yearly) stood at -$36.9 million in 2021, then skyrocketed by 166.86% to $24.7 million in 2022, then grew by 1.11% to $24.9 million in 2023, then slumped by 74.64% to $6.3 million in 2024, then soared by 158.26% to $16.3 million in 2025.